Evaluation of a Web-based Decision Aid Tool for Larynx Cancer (T3/T4) Patients.

Summary

Patients diagnosed with T3/T4 laryngeal cancer in general have several treatment options available, including total laryngectomy and/or (chemo-) radition. In order to help these patients in the decision making process, MAASTRO CLINIC designed and developed a web-based decision aid tool (Treatmentchoice). The aim of this study is twofold: user-testing Treatmentchoice using a systematically development process and establish the impact of Treatmentchoice on the decision making process.

The study covers 4 chronological activities: 1. assess decisional needs of patients and clinicians, 2. testing patients' and clinicians comprehensibility, acceptability and usability on the alpha-version of the tool, 3. establish the impact of Treatmentchoice on knowledge, decisional conflict and the shared decision making process, as well as the extent clinicians involve patients in decision making and 4. development of an implementation and dissemination plan for shared decision making which is based on the evaluation of barriers and facilitators for the use of patients decision aid tools in clinical practice.

A mixed method will be used. It comprises structured interviews combined with think aloud and questionnaires with stakeholders involved in the whole process (patients, medical doctors, nurses, general practitioners, patient organizations, and insurance companies).

Conditions

• Larynx Cancer

Interventions

OTHER

Interviews

Interviews with patients, physicians and general practitioners (GPs) to define patients' decisional needs

OTHER

Treatmentchoice Decisional Tool

Patients and physicians navigate through Treatmentchoice Decisional Tool and think aloud while running the tool

OTHER

Questionnaires

Patients and physicians fill out questionnaires on the usual care, Delphi study

OTHER

Interviews with stakeholders

Interviews with stakeholders Interviews with stakeholders (patients, clinicians, nurses, GP's, patient organizations, insurance companies) to determine the barriers and facilitators to the implementation of shared decision making and the decision aid.

Sponsors & Collaborators

• Maastricht University Medical Center

  collaborator OTHER

• The Netherlands Cancer Institute

  collaborator OTHER

• Maastricht Radiation Oncology

  lead OTHER

Principal Investigators

• Frank Hoebers, MD,PhD · Maastro Clinic, The Netherlands

Study Design

Allocation

NON_RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2015-09-30

Primary Completion

2015-12-31

Completion

2016-12-31

Countries

• Netherlands

Study Locations